Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
80,417,324
-
Share change
-
+342,872
-
Total reported value
-
$4,262,902,509
-
Put/Call ratio
-
49%
-
Price per share
-
$53.01
-
Number of holders
-
383
-
Value change
-
-$169,985,696
-
Number of buys
-
251
-
Number of sells
-
168
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2024
As of 30 Jun 2024,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
383 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,417,324 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Pictet Asset Management Holding SA, VIKING GLOBAL INVESTORS LP, and ALLIANCEBERNSTEIN L.P..
This page lists
383
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.